The Journal of Thoracic and Cardiovascular Surgery
Volume 136, Issue 1 , Pages 58-64 , July 2008

Spironolactone alleviates late cardiac remodeling after left ventricular restoration surgery

  • Masaki Tsukashita, MD

      Affiliations

    • Department of Cardiovascular Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan
    • Corresponding Author InformationAddress for reprints: Masaki Tsukashita, MD, Department of Cardiovascular Surgery, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawara, Sakyo, Kyoto 606-8507, Japan.
    • ,
  • Akira Marui, MD, PhD

      Affiliations

    • Department of Cardiovascular Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan
    • ,
  • Takeshi Nishina, MD, PhD

      Affiliations

    • Department of Cardiovascular Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan
    • ,
  • Eiji Yoshikawa, MD

      Affiliations

    • Department of Cardiovascular Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan
    • ,
  • Hideo Kanemitsu, MD, PhD

      Affiliations

    • Hamamatsu Rosai Hospital, Shizuoka, Japan
    • ,
  • Jian Wang, MD

      Affiliations

    • Department of Cardiovascular Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan
    • ,
  • Tadashi Ikeda, MD, PhD

      Affiliations

    • Department of Cardiovascular Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan
    • ,
  • Masashi Komeda, MD, PhD

      Affiliations

    • Department of Cardiovascular Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan

Received 16 May 2007 ,Revised 13 September 2007 ,Accepted 13 November 2007.

References 

  1. Komeda M, David TE, Malik A, Ivanov J, Sun Z. Operative risks and long-term results of operation for left ventricular aneurysm. Ann Thorac Surg. 1992;53:22–29
  2. Mickleborough LL, Maruyama H, Liu P, Mohamed S. Results of left ventricular aneurysmectomy with a tailored scar excision and primary closure technique. J Thorac Cardiovasc Surg. 1994;107:690–698
  3. Kesler KA, Fiore AC, Naunheim KS, Sharp TG, Mahomed Y, Zollinger TW, et al. Anterior wall left ventricular aneurysm repair. A comparison of linear versus circular closure. J Thorac Cardiovasc Surg. 1992;103:841–848
  4. Di Donato M, Barletta G, Maioli M, Fantini F, Coste P, Sabatier M, et al. Early hemodynamic results of left ventricular reconstructive surgery for anterior wall left ventricular aneurysm. Am J Cardiol. 1992;69:886–890
  5. Dor V, Saab M, Coste P, Kornaszewska M, Montiglio F. Left ventricular aneurysm: a new surgical approach. Thorac Cardiovasc Surg. 1989;37:11–19
  6. Dor V, Sabatier M, Di Donato M, Montiglio F, Toso A, Maioli M. Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular dysfunction: comparison with a series of large dyskinetic scars. J Thorac Cardiovasc Surg. 1998;116:50–59
  7. Nishina T, Nishimura K, Yuasa S, Miwa S, Nomoto T, Sakakibara Y, et al. Initial effects of the left ventricular repair by plication may not last long in a rat ischemic cardiomyopathy model. Circulation. 2001;104:I241–I245
  8. Sinatra R, Macrina F, Braccio M, Melina G, Luzi G, Ruvolo G, et al. Left ventricular aneurysmectomy; comparison between two techniques; early and late results. Eur J Cardiothorac Surg. 1997;12:291–297
  9. Nomoto T, Nishina T, Miwa S, Tsuneyoshi H, Maruyama I, Nishimura K, et al. Angiotensin-converting enzyme inhibitor helps prevent late remodeling after left ventricular aneurysm repair in rats. Circulation. 2002;106:I115–I119
  10. Tsuneyoshi H, Nishina T, Nomoto T, Kanemitsu H, Kawakami R, Unimonh O, et al. Atrial natriuretic peptide helps prevent late remodeling after left ventricular aneurysm repair. Circulation. 2004;110:II174–II179
  11. Nomoto T, Nishina T, Tsuneyoshi H, Miwa S, Nishimura K, Komeda M. Effects of two inhibitors of renin-angiotensin system on attenuation of postoperative remodeling after left ventricular aneurysm repair in rats. J Card Surg. 2003;18(Suppl 2):S61–S68
  12. White HD, Aylward PE, Huang Z, Dalby AJ, Weaver WD, Barvik S, et al. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Circulation. 2005;112:3391–3399
  13. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709–717
  14. Nishina T, Nishimura K, Yuasa S, Miwa S, Sakakibara Y, Ikeda T, et al. A rat model of ischemic cardiomyopathy for investigating left ventricular volume reduction surgery. J Card Surg. 2002;17:155–162
  15. Matsumoto R, Yoshiyama M, Omura T, Kim S, Nakamura Y, Izumi Y, et al. Effects of aldosterone receptor antagonist and angiotensin II type I receptor blocker on cardiac transcriptional factors and mRNA expression in rats with myocardial infarction. Circ J. 2004;68:376–382
  16. Silvestre JS, Heymes C, Oubenaissa A, Robert V, Aupetit-Faisant B, Carayon A, et al. Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation. 1999;99:2694–2701
  17. Suga H, Sagawa K. Instantaneous pressure-volume relationships and their ratio in the excised, supported canine left ventricle. Circ Res. 1974;35:117–126
  18. Weiss JL, Frederiksen JW, Weisfeldt ML. Hemodynamic determinants of the time-course of fall in canine left ventricular pressure. J Clin Invest. 1976;58:751–760
  19. Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II. Lancet. 2000;355:1582–1587
  20. Mill JG, Milanez Mda C, de Resende MM, Gomes Mda G, Leite CM. Spironolactone prevents cardiac collagen proliferation after myocardial infarction in rats. Clin Exp Pharmacol Physiol. 2003;30:739–744
  21. Hayashi M, Tsutamoto T, Wada A, Tsutsui T, Ishii C, Ohno K, et al. Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction. Circulation. 2003;107:2559–2565
  22. Lal A, Veinot JP, Leenen FH. Critical role of CNS effects of aldosterone in cardiac remodeling post-myocardial infarction in rats. Cardiovasc Res. 2004;64:437–447
  23. Modena MG, Aveta P, Menozzi A, Rossi R. Aldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after anterior myocardial infarction. Am Heart J. 2001;141:41–46
  24. Jorde UP, Vittorio T, Katz SD, Colombo PC, Latif F, Le Jemtel TH. Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure. Circulation. 2002;106:1055–1057
  25. Katada J, Meguro T, Saito H, Ohashi A, Anzai T, Ogawa S, et al. Persistent cardiac aldosterone synthesis in angiotensin II type 1A receptor-knockout mice after myocardial infarction. Circulation. 2005;111:2157–2164

PII: S0022-5223(07)01922-8

doi: 10.1016/j.jtcvs.2007.11.016

The Journal of Thoracic and Cardiovascular Surgery
Volume 136, Issue 1 , Pages 58-64 , July 2008

Article Tools

* Image Usage & Resolution